Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
, 40 (9), 1131-8

Digestive Enzyme Supplementation for Autism Spectrum Disorders: A Double-Blind Randomized Controlled Trial

Affiliations
Randomized Controlled Trial

Digestive Enzyme Supplementation for Autism Spectrum Disorders: A Double-Blind Randomized Controlled Trial

Sujeeva A Munasinghe et al. J Autism Dev Disord.

Abstract

To examine the effects of a digestive enzyme supplement in improving expressive language, behaviour and other symptoms in children with Autism Spectrum Disorder. Randomized, double-blind placebo-controlled trial using crossover design over 6 months for 43 children, aged 3-8 years. Outcome measurement tools included monthly Global Behaviour Rating Scales, Additional Rating Scales of other symptoms by parents and therapists, and monthly completion of the Rescorla Language Development Survey. Compared with placebo, treatment with enzyme was not associated with clinically significant improvement in behaviour, food variety, gastrointestinal symptoms, sleep quality, engagement with therapist, or the Language Development Survey Vocabulary or Sentence Complexity Scores. A small statistically significant improvement on enzyme therapy was seen for the food variety scores. No clinically significant effect improvement of autism symptoms with enzyme use was shown with this trial, however, possible effects on improvement in food variety warrants further detailed investigation.

Similar articles

See all similar articles

Cited by 12 PubMed Central articles

See all "Cited by" articles

References

    1. J Speech Hear Disord. 1989 Nov;54(4):587-99 - PubMed
    1. Pediatr Clin North Am. 2007 Dec;54(6):983-1006; xii - PubMed
    1. J Autism Dev Disord. 2007 Apr;37(4):628-36 - PubMed
    1. Aliment Pharmacol Ther. 2002 Apr;16(4):663-74 - PubMed
    1. Acta Paediatr. 1996 Sep;85(9):1076-9 - PubMed

Publication types

Feedback